Malignant diseases
Conditions
Interventions
Group 1: Pseudonymized data sets, which were collected in the respective center according to the uniform basic oncology data set and its modules of the ADT and the GEKID, and reported to the responsib
Sponsors
Krukenberg Krebszentrum Halle
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age > 18 years - newly diagnosed malignant tumors according to ICD-10 in 2018, 2019, and 2020
Exclusion criteria
Exclusion criteria: - Patients actively contradicting the consent for data collection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of newly diagnosed malignant tumors according to ICD-10 per month in 2020 compared to 2018 and 2019. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of newly diagnosed malignancies, differentiated by individual tumor entity (monthly comparison between the years 2020, 2019 and 2018) - Interval between diagnosis and initiation of therapy, differentiated by individual tumor entity (monthly comparison between 2020, 2019, and 2018) - Stage of disease in solid neoplasms (TNM) at the time of diagnosis differentiated by individual tumor entities (monthly comparison between the years 2020, 2019, and 2018) - Outcome of disease (survival, event-free survival, recurrence incidence, and mortality incidence) at 1 and 2 years (comparison between new diagnoses in 2020, 2019, and 2018) - Influence of patient-related factors (age, sex, geographic residence based on zip code) on primary and above secondary endpoints. - Influence of disease-related factors (diagnosis, time of diagnosis, interval between diagnosis and initiation of therapy, TNM) on outcome. | — |
Countries
Germany
Contacts
Public ContactHaifa Kathrin Al-Ali
Krukenberg Krebszentrum HalleUniversitätsklinikum Halle (Saale)
Outcome results
None listed